ALPS Advisors’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $811K | Sell |
34,441
-12,071
| -26% | -$284K | ﹤0.01% | 564 |
|
|
2025
Q1 | $1.12M | Sell |
46,512
-4,695
| -9% | -$113K | 0.01% | 453 |
|
|
2024
Q4 | $2.17M | Buy |
51,207
+6,941
| +16% | +$294K | 0.01% | 338 |
|
|
2024
Q3 | $1.96M | Buy |
44,266
+1,432
| +3% | +$63.3K | 0.01% | 363 |
|
|
2024
Q2 | $1.55M | Buy |
42,834
+4,102
| +11% | +$148K | 0.01% | 376 |
|
|
2024
Q1 | $1.67M | Buy |
38,732
+8,512
| +28% | +$367K | 0.01% | 381 |
|
|
2023
Q4 | $465K | Sell |
30,220
-2,490
| -8% | -$38.3K | ﹤0.01% | 617 |
|
|
2023
Q3 | $448K | Buy |
32,710
+175
| +0.5% | +$2.4K | ﹤0.01% | 611 |
|
|
2023
Q2 | $522K | Buy |
32,535
+4,906
| +18% | +$78.7K | ﹤0.01% | 608 |
|
|
2023
Q1 | $214K | Buy |
27,629
+8,880
| +47% | +$68.9K | ﹤0.01% | 979 |
|
|
2022
Q4 | $363K | Buy |
18,749
+4,005
| +27% | +$77.5K | ﹤0.01% | 720 |
|
|
2022
Q3 | $314K | Sell |
14,744
-1,316
| -8% | -$28K | ﹤0.01% | 708 |
|
|
2022
Q2 | $219K | Buy |
+16,060
| New | +$219K | ﹤0.01% | 980 |
|